Exploring the impact of GSTM1 as a novel molecular determinant of survival in head and neck cancer patients of African descent.

This study identifies GSTM1 as a novel molecular determinant of survival in HNSCC patients of African descent. It also provides a molecular basis for future research focused on identifying molecular determinants and developing therapeutic interventions to improve outcomes for BAA patients with HNSCC.